Department of Surgery, University of Alabama at Birmingham, Birmingham Alabama.
Department of Surgery, University of Alabama at Birmingham, Birmingham Alabama.
J Surg Res. 2024 Oct;302:144-149. doi: 10.1016/j.jss.2024.07.051. Epub 2024 Aug 2.
Adrenal incidentalomas (AIs) are found in 3%-4% of abdominal computed tomography scans. Timely evaluation of their functional status and malignant potential is necessary to guide nonoperative surveillance or surgery. This study aims to evaluate the adherence of referring service patterns to the American Association of Endocrine Surgeons and American Association of Clinical Endocrinologists guidelines for the biochemical workup of AIs at a tertiary surgical clinic.
We conducted a retrospective study of 125 patients evaluated for AIs at the endocrine surgery clinic between 2017 and 2022. Information on patient demographics, referral source, and reasons for referral was collected. The appropriateness of the biochemical workup for AIs by referring physicians was assessed. Statistical analyses included chi-square and Kruskal-Wallis tests.
Referrals came from endocrinologists (44.8%), other subspecialists (31.2%), and primary care physicians (PCPs) (19.2%). Among 125 patients, diagnoses included benign adrenal masses (52.8%), aldosteronomas (10.4%), cortisol-secreting tumors (15.2%), pheochromocytomas (12.8%), and metastatic masses (4.0%). Endocrinologists were more likely to conduct a complete biochemical workup compared to other subspecialties and PCPs (P < 0.001). Eighty-three (66.4%) patients underwent adrenalectomy, with those referred by endocrinologists more likely to undergo surgery than those referred by other subspecialties and PCPs (P < 0.001). There was no significant difference in the time from the initial clinic visit to surgery by referral source (P > 0.05).
Over half of AIs referrals to the endocrine surgery clinic came from subspecialists and PCPs rather than endocrinologists. Familiarizing all referring physicians with American Association of Endocrine Surgeons/Association of Clinical Endocrinologists guidelines may reduce undiagnosed functional AI cases and facilitate timely surgical management.
在腹部计算机断层扫描中,肾上腺偶发瘤(AIs)的检出率为 3%-4%。及时评估其功能状态和恶性潜能对于指导非手术监测或手术至关重要。本研究旨在评估在一家三级外科诊所,内分泌外科医生和临床内分泌协会指南在评估 AIs 生化检查方面的应用情况。
我们对 2017 年至 2022 年间在内分泌外科诊所评估的 125 例 AIs 患者进行了回顾性研究。收集了患者人口统计学、转诊来源和转诊原因等信息。评估了转诊医生对 AIs 生化检查的适宜性。统计分析包括卡方检验和 Kruskal-Wallis 检验。
转诊来源包括内分泌科医生(44.8%)、其他亚专科医生(31.2%)和初级保健医生(PCPs)(19.2%)。在 125 例患者中,诊断包括良性肾上腺肿块(52.8%)、醛固酮瘤(10.4%)、皮质醇分泌肿瘤(15.2%)、嗜铬细胞瘤(12.8%)和转移性肿块(4.0%)。与其他亚专科医生和 PCPs 相比,内分泌科医生更有可能进行完整的生化检查(P<0.001)。83 例(66.4%)患者接受了肾上腺切除术,其中由内分泌科医生转诊的患者比由其他亚专科医生和 PCPs 转诊的患者更有可能接受手术(P<0.001)。不同转诊来源患者从首次就诊到手术的时间无显著差异(P>0.05)。
超过一半的 AIs 转诊至内分泌外科诊所来自亚专科医生和 PCPs,而非内分泌科医生。使所有转诊医生熟悉美国内分泌外科医生协会/临床内分泌协会指南可能会减少未确诊的功能性 AI 病例,并促进及时的手术治疗。